A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.
This latest milestone in the patch's development was made possible by a combined $21 million in support from a state organization, a nonprofit foundation and the university. Last month, the California Institute for Regenerative Medicine awarded an estimated $12.4 million to the USC-supported startup Regenerative Patch Technologies to test the safety and efficacy of the patch for treating advanced dry age-related macular degeneration, also known as "geographic atrophy.
I want to thank USC President Carol L. Folt for supporting this important research, as well as USC Research and Innovation for all the work they did to make this possible. I would also like to thank The Marcus Foundation for their generous support after a thorough review process." "We are thrilled to support this critically important medical innovation by fostering the university's ongoing technology transfer and commercialization efforts through faculty partnerships with small businesses," said Ishwar K. Puri, senior vice president for USC Research and Innovation.
The disease affects a vital group of cells: retinal pigment epithelium cells. When healthy, these cells enable photoreceptor cells of the retina to detect light. With geographic atrophy, RPE cells degenerate over time. This can lead to photoreceptor loss, impaired vision and, for many, blindness, forcing some patients to lose their independence.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Feldman's preseason Top 25: Michigan, LSU and USC lead the wayGeorgia may be No. 1 in the polls, but here's why I have Michigan atop my preseason rankings.
Lire la suite »
Scientists discover mutations in blood stem cells can exacerbate colon cancerResearchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.
Lire la suite »
Gene editing system restores dystrophin function in stem cells from patients with Duchenne muscular dystrophyDuchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. On August 24 in the journal Stem Cell Reports, researchers show how a dual CRISPR RNA method restored dystrophin protein function in induced pluripotent stem cells derived from DMD patients.
Lire la suite »
College football Week 0 odds, picks: Notre Dame-Navy, Caleb Williams highlight openersNotre Dame and USC are both in action in college football's Week 0. There are seven games in action in total.
Lire la suite »
ENVE Pressure Relief Nut saves you from blowing up your rims!ENVE creates simple Pressure Relief Valve Stem Nuts that promise a low-cost solution to protect expensive carbon wheels from high-pressure tubeless damage.
Lire la suite »
Lower-middle class Americans near retirement are worse off than 20 years ago, new study showsLower-middle class Americans nearing retirement age are worse off than their counterparts more than two decades ago, while upper-middle Americans have largely seen their life expectancy and wealth improve. Policymakers, meanwhile, overlook the lower middle group of Americans who don't qualify for many assistance programs. That's according to a new study by the USC Schaeffer Center for Health Policy & Economics and the Columbia University Mailman School of Public Health.
Lire la suite »